Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106671856 | 10667185 | 6 | F | 20140916 | 20160912 | 20141222 | 20160919 | EXP | JP-JNJFOC-20141209797 | JANSSEN | 76.46 | YR | E | M | Y | 68.00000 | KG | 20160919 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106671856 | 10667185 | 1 | PS | SOVRIAD | SIMEPREVIR | 1 | Oral | N | 205123 | 100 | MG | CAPSULE | QD | ||||||
| 106671856 | 10667185 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 0 | 800 | MG | UNSPECIFIED | QD | ||||||
| 106671856 | 10667185 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 0 | 400 | MG | UNSPECIFIED | QD | ||||||
| 106671856 | 10667185 | 4 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 0 | 600 | MG | UNSPECIFIED | QD | ||||||
| 106671856 | 10667185 | 5 | C | PEGINTERFERON ALFA-2B | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | D | 0 | 1.1 | UG/KG | INJECTION | /wk | ||||||
| 106671856 | 10667185 | 6 | C | TEPRENONE | TEPRENONE | 1 | Oral | D | 0 | 150 | MG | CAPSULE | QD | ||||||
| 106671856 | 10667185 | 7 | C | LOXOPROFEN SODIUM | LOXOPROFEN SODIUM | 1 | Oral | WHEN NECESSARY | D | 0 | 60 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106671856 | 10667185 | 1 | Chronic hepatitis C |
| 106671856 | 10667185 | 2 | Chronic hepatitis C |
| 106671856 | 10667185 | 3 | Chronic hepatitis C |
| 106671856 | 10667185 | 4 | Chronic hepatitis C |
| 106671856 | 10667185 | 5 | Chronic hepatitis C |
| 106671856 | 10667185 | 6 | Prophylaxis |
| 106671856 | 10667185 | 7 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106671856 | 10667185 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106671856 | 10667185 | Haemoglobin decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106671856 | 10667185 | 1 | 20140812 | 20141103 | 0 | |
| 106671856 | 10667185 | 2 | 20140812 | 20140915 | 0 | |
| 106671856 | 10667185 | 3 | 20141014 | 20150216 | 0 | |
| 106671856 | 10667185 | 4 | 20140916 | 20141013 | 0 | |
| 106671856 | 10667185 | 5 | 20140812 | 20150216 | 0 | |
| 106671856 | 10667185 | 6 | 20140812 | 20150215 | 0 | |
| 106671856 | 10667185 | 7 | 20140812 | 20150215 | 0 |